Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone

PURPOSE: Transarterial chemoembolization is accepted therapy for hepatocellular carcinoma (HCC). No randomized trial has demonstrated superiority of chemoembolization compared with embolization, and the role of chemotherapy remains unclear. This randomized trial compares the outcome of embolization...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Brown, Karen T., Do, Richard K., Gonen, Mithat, Covey, Anne M., Getrajdman, George I., Sofocleous, Constantinos T., Jarnagin, William R., D’Angelica, Michael I., Allen, Peter J., Erinjeri, Joseph P., Brody, Lynn A., O’Neill, Gerald P., Johnson, Kristian N., Garcia, Alessandra R., Beattie, Christopher, Zhao, Binsheng, Solomon, Stephen B., Schwartz, Lawrence H., DeMatteo, Ronald, Abou-Alfa, Ghassan K.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2016
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4966514/
https://ncbi.nlm.nih.gov/pubmed/26834067
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2015.64.0821
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados